E-LIB Suche - Ergebnisse für: Elisabet Manasanch

1

P-399 Isatuximab promotes immune activation in the bone mar..:

Marques-Piubelli, Mario ; Duenas, Daniela ; Pandurengan, Renganayaki...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S260-S261 , 2023

Link: https://doi.org/10.1016/..

2

OA-36 SBCMA predicts progression and is a biomarker of resp..:

Tan, Wei ; Kunacheewa, Chutima ; Becnel, Melody...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S22 , 2023

Link: https://doi.org/10.1016/..

3

Safety and Efficacy of a New High-Dose Chemotherapy (HDC) R..:

Nieto, Yago ; Yang, Zixi ; Valdez, Ben C....
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S31-S32 , 2023

Link: https://doi.org/10.1016/..

4

NSO-02 Characteristics of multiple myeloma patients with ce..:

Chen, Jessica ; Richards, Tiffany ; Allen, Christy...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S310 , 2023

Link: https://doi.org/10.1016/..

5

P1303: DARATUMUMAB-BASED MAINTENANCE IN PATIENTS WITH RELAP..:

Pasvolsky, Oren ; Patel, Krina K. ; Bashir, Qaiser...
HemaSphere. 7 (2023) S3 - p. e002748c , 2023

Link: https://doi.org/10.1097/..

6

P-258: Real-world experience with isatuximab in patients wi..:

Martin, Thomas ; Beksac, Meral ; Cavo, Michele...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S178 , 2022

Link: https://doi.org/10.1016/..

7

P-233: Retrospective, single-center, real-world experience ..:

Becnel, Melody ; Ferreri, Christopher ; Feng, Lei...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S163-S164 , 2022

Link: https://doi.org/10.1016/..

8

P-008: Single center, real-world, retrospective assessment ..:

Ferreri, Christopher ; Kalariya, Nilesh ; Hawkins, Misha...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S40-S41 , 2022

Link: https://doi.org/10.1016/..

9

P-189: Updated trial in progress: understanding treatment e..:

Manasanch, Elisabet ; Banerjee, Rahul ; Brassil, Kelly..
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S139 , 2022

Link: https://doi.org/10.1016/..

10

Poster: CT-511 Clinical Characteristics and Response Outcom..:

Kalariya, Nilesh ; Ferreri, Christopher ; Dillard, Christen...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S188 , 2022

Link: https://doi.org/10.1016/..

11

Daratumumab-Based Maintenance in Patients with Relapsed Mul..:

Qazilbash, Muzaffar H. ; Bashir, Qaiser ; Rauf, Mikael...
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S404-S405 , 2022

Link: https://doi.org/10.1016/..

12

CT-511 Clinical Characteristics and Response Outcomes in Ol..:

Kalariya, Nilesh ; Ferreri, Christopher ; Dillard, Christen...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S446 , 2022

Link: https://doi.org/10.1016/..

13

KRD vs. VRD as Induction before Autologous Hematopoietic Pr..:

Gaballa, Mahmoud ; Ma, Junsheng ; Tanner, Mark R....
Transplantation and Cellular Therapy. 28 (2022) 3 - p. S406-S407 , 2022

Link: https://doi.org/10.1016/..

14

Impact of Induction with VRD Vs. VCD on the Outcome of Pati..:

Afrough, Aimaz ; Srour, Samer ; Bashir, Qaiser...
Transplantation and Cellular Therapy. 27 (2021) 3 - p. S405-S406 , 2021

Link: https://doi.org/10.1016/..

15

P-132: Trial in progress: a mixed methods approach to under..:

Manasanch, Elisabet ; Banerjee, Rahul ; Brassil, Kelly.
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S107 , 2021

Link: https://doi.org/10.1016/..